投稿信息

投稿信息
審稿費(fèi)用
暫無數(shù)據(jù)
版面費(fèi)用
暫無數(shù)據(jù)
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量4.56% (2022年為13.49%)
自引率
4.4 %
年文章數(shù)
2212
期刊官網(wǎng)
點(diǎn)擊查看 (點(diǎn)擊次數(shù):12063)
投稿鏈接
點(diǎn)擊查看 (點(diǎn)擊次數(shù):3498次)
作者需知
暫無數(shù)據(jù)
期刊簡(jiǎn)介
稿件收錄要求

With a revised editorial board in place, Leukemia Research is further developing its goal of bringing comprehensive and current information to all health care professionals involved in basic research and applied clinical research in both leukemias and other hematologic malignancies. The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology, molecular biology as well as epidemiologic and clinical studies. Specifically, of major interest will be articles that encompass the application of oncogenes, growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition we solicit selected articles on the rapidly increasing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients with a wide range of neoplasms.For more information contact the Myelodysplastic Syndromes Foundation at http://www.mds-foundation.org/